Cardiac Resynchronization Therapy: Clinical Trials

1 trial of Cardiac Resynchronization Therapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1
Phase 31Terminated 1

Follow Cardiac Resynchronization Therapy: new trials by email Literature Review of Cardiac Resynchronization Therapy trials Research Report on Cardiac Resynchronization Therapy

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Echocardiography Guided Cardiac Resynchronization Therapy (EchoCRT)
Implantable Cardioverter Defibrillator with Cardiac Resynchronization Therapy (BIOTRONIK Lumax HF-T CRT-D) - Heart Failure, Ventricular Dyssynchrony
Phase 2 / Phase 3TerminatedBiotronik, Inc.16802008-08-012018-01-17

Conditions studied

Heart Diseases (1)  ·  Heart Failure (1)

Sponsors

Biotronik, Inc. (1)

Countries

Australia (1)  ·  Austria (1)  ·  Belgium (1)  ·  Canada (1)  ·  Czechia (1)  ·  Denmark (1)  ·  France (1)  ·  Germany (1)  ·  Israel (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Portugal (1)  ·  Spain (1)  ·  Switzerland (1)

Top investigators

Frank Ruschitzka, MD (1)  ·  Jagmeet Singh, MD (1)  ·  Johannes Holzmeister, MD (1)  ·  William Abraham, MD (1)

Results publications

PMID 23998714, PMID 27282848, PMID 29566816, PMID 29807890